In Table I it will be seen that only just under 9 % of these tumours are reasonably benign -these are the cerebellar astrocytomas and ependymomas. If a cerebellar astrocytoma, the common tumour of childhood, be completely removed it does not recur and many of our early cases are still alive and well. Much longer survival periods are common but in the present series there are two cases of recurrences eleven and twelve years after a primary removal. This raises the question as to how often complete removal is possible: certainly it is not possible if the tumour extends into the brain-stem, and this occurred in no less than 11 of our 44 cases, i.e. in 25 %. But there is every reason for pursuing a cerebellar astrocytoma with the utmost vigour. If an irremovable extension is found, there may still be a long period of useful survival and in one case there has been good evidence of response to radiation therapy.
I have been a little disappointed to find that it is not uncommon for children who have had complete removals done in early childhood to grow up with slight mental defects or behaviour disorders which may lead to difficulties in social adjustment. *This may be the result of the long-standing hydrocephalus which usually exists in these cases before they come for treatment. The defect is rarely serious but it may mar what is otherwise a complete recoverv.
Two technical matters are worth mentioning. The first is that in the case of infants and small children it is safer to remove the tumour in two stages rather than at one session. At the first operation a decompression is done, the tumour is verified, and if there is a cyst present it is tapped. We then prefer to wait for three to four months to allow an adjustment to the altered pressure relationships afforded by the decompression. At the second operation, the tumour can be taken out with a good deal more safety and less post-operative worry than if the whole procedure had been done in one stage.
The second point is that all of these lesions causing hydrocephalus should be verified if at all possible. There is a current vogue for easy short-circuiting procedures such as ventriculocisternostomy and ventriculostomy for hydrocephalus, and remediable lesions may be missed if care is not taken to be certain just what is causing the hydrocephalus.
MAY-NEUROL. I Fig. 1 shows the ventriculogram in a boy of 16 who had had periodic occipital headache for seven years, and some unsteadiness of gait for one year. On examination in October 1940 there was some enlargement of the skull, bilateral papillcedema, no nystagmus, and slight generalized unsteadiness of his limbs. The ventriculogram (A-B, Fig. 1 ) we interpreted as indicating hydrocephalus due to stenosis of the aqueduct, as only the upper part of the aqueduct could be filled and it ended in a sharp point as is commonly seen in this condition. We made an anterior ventriculostomy (incision of the lamina terminalis) and this seemed to be effective as the headache ceased and the papilleedema subsided. But there was little improvement in the neurological status and because of this he was readmitted ten months later and the ventriculogram was repeated. The ventricles (C-D, Fig. 1 ) were smaller and an air shadow could be seen at the site of the fistula indicating that it was effective. The posterior end of the third ventricle was deformed and we then thought that the lesion had all along been a brain-stem tumour which was now growing up into the third ventricle. He died suddenly two months later and at autopsy there was a large cystic and solid astrocytoma of the vermis. Had we even inspected the posterior fossa in this case, the result might have been different. X-ray treatment was given after operation and he has remained well up to the present time, seven years after operation. It is thus worth approaching these tumours with somewhat more optimism than is so far justified when they occur in childhood. For the latter, which constitutes the bulk of the problem, surgery must be followed by radiotherapy, and improved techniques do hold out some promise: Lampe and MacIntyre report that although 17 of their 25 patients succumbed within 38 months, l lived for 68 months, and 7 (28%) survived for periods ranging from 33 to 92 months (33, 47, 50, 70, 72, 83, and 92) . These are the best results that I know of with this type of tumour, and I hope they will stimulate our colleagues in radiotherapy to increase their efforts.
Turning now to the tumours of the cerebral hemispheres which account for about 80% of all gliomata, and about half of which are spongioblastoma multiforme. .. 30
It has been known from the early days of brain surgery that these are unfavourable tumours, but I doubt whether any of us realize quite how bad they are until we are faced with figures. We operate on these patients, they often get out of hospital, we see them at the follow-up clinic once or twice, and we forget them in the welter of new cases and of the more benign types which keep on coming up year after year. But in fact 110 of these 282 patients died in hospital. In the majority of these, death was accelerated by a ventriculogram and biopsy and in most it was a merciful release. 83 patients survived the procedures involved in verifying the lesion-and in this connexion I should say that arteriography and burr-hole biopsy seem to be a good deal less lethal than ventriculography and biopsybut in all cases the patient was described as deteriorating on discharge from hospital and there were no useful survivals.
This leaves 89 cases in which the circumstances were such that we considered some major intervention worth while, in most cases with a view to radiation treatment subsequently. These procedures ranged from decompressions to complete removal although usually the removal was known to be incomplete and the operation really amounted to an internal decompression. There were 14 operative deaths in this group, a mortality rate of 160%. Of the 75 survivors, 38 were known to be dead within 16 months, 6 survived for periods from 18 to 33 months, one for 48 months and one for 51 months. One patient is still alive and well 51 months after removal of the tumour (vide infra). In all cases recurrence of the tumour seemed to be the cause of death. Of the remaining 28 cases, we have no final note of death, but in almost all of them there was evidence of deterioration within six months of operation, and it is safe to assume that they died shortly afterwards.
These figures relate to the survival period, but if we consider them from the point of useful survival, the aspect is even more sombre. Of course the term useful survival is somewhat arbitrary: what might be so regarded by an optimistic surgeon might be quite differently assessed by the patient's relatives, and vice versa. We have taken as a rough standard, a man's ability to return to his work, or to some wage-earning occupation, and in the case of women, the ability to return to housework, shopping, and the care of their family, &c. There is an additional factor and that is the duration of useful survival, and this is even more arbitrary than our definition of useful survival. It usually takes at least a month for a patient to convalesce from his surgical experiences, and even though he returns to work for a month, and then has a recurrence, it may be doubted whether this month should count as useful survival, and in my opinion it should not. I see no humanity in snatching a person from the jaws of death, his working for a month or two, and then having to undergo a fatal illness for the second time. Such cases I have discarded, and I find that of our whole material there were only 30 cases of useful survival, 18 of them survived usefully for periods up to 6 months, 3 for 9 months, 3 for 12 months, 2 for 24 months, one each for 30 and 33 months, one for 48 months, and one for 51 months.
The general trend of these figures has been apparent for several years, and to be realistic about these tumours in the present state of our hospital services, the most important thing about them is histological verification. All of us have had the experience, not once or twice but many times, of being faced with the case in which there is every reason to diagnose a rapidly growing glioma, and which at operation or autopsy proves to be a meningioma, subdural hematoma, abscess or the like. The differentiation cannot be made on clinical evidence, nor will electro-encephalography, ventriculography or arteriography always provide the right answer. We have seen a practitioner with an almost unique experience of arteriography mistake a spongioblastoma multiforme for a meningioma, and on the next day making the opposite mistake. The only certain way is histological verification and this means a biopsy after accurate localization by arteriography or ventriculography. In cases in which there is already profound disability such as aphasia, hemiplegia or mental derangement, and when the diagnosis ofspongioblastoma multiforme is proved histologically, we think surgery has nothing to offer. Heroic operations may prolong existence for a few months, but this usually means that some other member of the family is sacrificed to look after the invalid, and the social havoc which may result from such surgery is often appalling. (Fig. 2) . Early diagnosis.-On general grounds it might be supposed that if we could get these tumours early enough, and remove them when they are small the outlook might be better.
In this connexion I should mention 2 cases
The first was a man of 37, who was operated on in August 1939. He had a small, apparently circumscribed glioma in the right mid-frontal cortex measuring 2-5 cm. in diameter. It was removed completely with a liberal surrounding of normal white matter, and we thought that the outlook was good, as this seemed to be a small tumour, detected early, and removed completely. This patient was dead in January 1940, five months after operation, and at the autopsy the tumour measured 9 x 9 x 6 cm. and occupied both frontal lobes and the corpus callosum. He had had no X-ray treatment.
T'he second case is a woman of 38, who had a tumour of about the same size (3 cm. in diameter)
removed from the cortex of the right parietal region mn August 1945. It, too, appeared to be circumscribed, and was removed in a block of tissue measuring 6 x 4 x 3 cm. She had a course of radiation after the operation and is alive and well at present, 41 years after operation.
T'hese two cases stress at once the despair and the unpredictability which attend the surgery of the gliomata. They also add emphasis to a theme which has kept recurring throughout my remarks, that surgery alone is powerless in the management of many of these tumours and that the combined efforts of surgeon and radiotherapist are essential. In conclusion I would like to mention a case which we have in hospital at present:
A woman of 34, who was admitted in November 1939, with headache, vomiting, occasional epileptic attacks, papillcedema, some mental derangement and little in the way of other physical abnormalities.
T'he ventriculogram (Fig. 3) [1939] [1940] [1941] [1942] [1943] [1944] . They include several cases from the time when Sir Hugh Cairns was at the London Hospital, patients who have since then been under my observation. I shall not deal with the cerebellar astrocytomas, the medulloblastomas, or the gliomata of the brain-stem. There are 58 cases of glioblastoma (spongioblastoma) multiforme in which a full follow-up is available. Many of these patients died in hospital without major craniotomy, although in such some diagnostic measure was usually employed in order to confirm the diagnosis. In the others an attempt was made to remove the tumour as completely as seemed compatible with useful existence, and radiotherapy was given in many.
The results are such as Mr. Pennybacker has described; an occasional patient survived for over a year, in fact 4 for over two years. But one patient is still alive and deserves comment.
At operation in 1943, six years ago, the tumour-a small one in the frontal lobe-was removed with a good margin of brain. The patient received X-ray treatment and returned to work. Four years later in 1947 there were focal signs suggestive of a recurrence, but these mostly disappeared spontaneously and were presumably the result of a focus of radionecrosis. There has been no further evidence of deterioration.
The next group comprises 39 cases of cerebral astrocytoma, and in Fig. I is set out a graphic representation of the length of history in years before operation, and of postoperative survival. The queries denote some doubt as to the precise length of history, and the precise date of death. In 7 patients death occurred without any operation, or following biopsy by needling, and in another 7 death followed major craniotomy. In some no attempt was made to remove the tumour, in others the removal was frankly partial and therefore recognized as palliative, in a few it appeared to the naked eye that the tumour had been removed completely. The late results appear unaffected by the operative procedure. There have been a few cases of long survival; up to a maximum of seven years in a woman now dead in whom the tumour quite obviously was inoperable, but the seven years were useful years during which she became happily married. 3 patients have lived for over five years, and 6 for over four years. 2 patients are still alive, one 51 years after evacuating a cyst, and removing some tumour for histology; and in the other the tumour appeared macroscopically localized and was thought to be completely extirpated. This impression was given support by Dr. Greenfield possibly post-traumatic. There was only equivocal weakness of the left limbs. X-ray of the skull showed a fleck of calcification in the right frontal lobe, and an encephalogram showed some dilatation of the right ventricle. Exploratory craniotomy revealed shrunken gyri, no biopsy was performed, and the diagnosis of post-traumatic epilepsy seemed correct. He was observed regularly, and his fits fluctuated in degree and in frequency. In 1948, that is thirteen years after the onset of fits, they became worse, and the slight weakness of the left limbs became more definite. Encephalography now revealed a typical tumour defect, and at craniotomy a massive oligodendroglioma was encountered; he died shortly afterwards.
The other group of hemisphere gliomata I wish to mention are the ependymomata. There have been only 5 in the period under review, 3 in the third ventricle, 1 in the lateral ventricle and hemisphere, and 1 in the cerebrum not apparently attached to the ventricle. The results have been bad. 2 of the third ventricle tumours died as a result of the operation; the third died of a recurrence a year after operation, at which the tumour seemed to be completely removed, as it appeared only lightly adherent to the walls of the ventricle. Of the lateral tumours, one survived a year; the other three-and-a-half years, a second attempt to remove a recurrence of the tumour which seemed completely removed at the first being equally fruitless. My experience with the fourth ventricle tumours is similar to that of Mr. Pennybacker; provided the enucleation is complete-and this endeavour may make the operation lethal-the results are as good as with the cerebellar astrocytoma.
The treatment of gliomata is a gloomy business, with the exception of certain well-defined entities, viz. the cerebellar astrocytoma and ependymoma. But there are the occasional cases which survive for long periods, whatever procedure is carried out, and these at first sight seem to confuse rather than to clarify the picture. This I believe is due to a fundamental misconception of the nature of the tumours we are dealing with. The surgeon is apt to believe when he removes apparently completely a compact mass of tumour-perhaps a so-called mural nodule in the wall of a cyst-and histologically diagnosed as an astrocytoma that he has removed a benign tumour. But surely nothing is further from the truth. Carmichael in 1928 and Scherer more recently have shown very clearly that the astrocytoma is a diffuse and infiltrating tumour, extending microscopically far beyond the confines of the macroscopically visible tumour. The use of the adjective "benign" for a glioma is a misnomer if it implies, as it should, an encapsulated tumour. Scherer divides the manner of growth of the gliomata into expansive and infiltrative; expansive growth pushes aside brain tissue with a minimum of infiltration, thus simulating a benign biological characteristic. He states that only the ependymoma has this manner of growth, and that not always. Growth by infiltration is shown by all other gliomata to varying degrees, and moreover this property does not correspond with the malignancy of the cells. The cerebral astrocytoma he considers the most invasive of all gliomata, but amongst the glioblastomata some 200% are found in which invasiveness is relatively circumscribed. The oligodendroglioma is similarly less invasive than the astrocytoma. The other important distinction which Scherer emphasizes, which we probably all appreciate but do not constantly bear in mind, is that invasion by tumour does not necessarily mean the destruction of the nervous tissue involved; invasion can occur with, and without, destruction. This is of great clinical importance in the natural history or the biology of the slow-growing astrocytoma and oligodendroglioma. Tumour may be present for many years, perhaps causing epilepsy but causing no significant neurological deficit. Such patients may ultimately need operation for the relief of raised intracranial pressure, the evacuation of cysts, and partial removal of the tumour may provide a useful internal decompression, but the surgeon cannot hope to do more.
Another problem is the varying histological picture which a tumour may present in different areas. If the surgeon receives a report that the tissue he removed is a glioblastoma, he has no assurance that the part left behind may not be predominantly astrocytoma and more slowly growing, and so his case of glioblastoma will perhaps survive for a surprisingly long time. The reverse holds true, that his patient with an astrocytoma may die in a few months, and if he has not the fortune to obtain the brain he will not learn the histology of the remaining part of the tumour which may be anaplastic.
If we examine again the chart of astrocytomata we find that some show long histories, with long post-operative survival. Others of this group show no such relation, and in others the evolution has been entirely rapid. Surely the explanation of these anomalies is that the group is not a homogeneous one, but a mixture of cases of slowly growing and of rapidly growing tumours and probably varying their invasive and destructive powers. They have different biological qualities which are not reflected in the name astrocytoma, which is attached to them.
Finally, in the surgery of the glioblastomata we have to face the possibility that in some patients, even if the tumour be removed with a good margin of healthy tissue, there may be a recurrence, not as a result of leaving behind some of the tumour, but because of the multicentric origin of some glioblastomata. The present practice in the treatment of gliomata is, in the first place, an attempt at a pathological diagnosis. This may often be suspected from the clinical picture, and angiography may give valuable help. Clearly when there is doubt between a glioblastoma and a meningioma, the old-fashioned method of placing greater reliance on clinical judgment than on ancillary methods will usually lead to exploration. In some cases, the circumstances will suggest biopsy by needling; in the series of glioblastomata under review this was undertaken in 40 patients, providing a positive histological diagnosis in 13, equivocal findings such as cyst fluid or a doubtful histological report in 14, and it was uninformative in 13. If a glioblastoma is diagnosed, the trend nowadays is to avoid operation, and this I believe to be correct when the tumour is invading eloquent areas of the brain. But in certain cases operation should be carried out, on humane grounds to relieve suffering where death is not imminent, and in those cases in which there is some reason to believe that a total enucleation may be possible. In these cases, more surgery and more radicai surgery seems the right direction in the future.
It has been shown that a glioblastoma may possess a false line of cleavage around its margin. This may be due to a narrow marginal zone of necrosis, misleading to the surgeon, who by following this plane leaves behind a thin rind of active tumour. In other cases the tumour is surrounded by gliosis, a form of capsule, which makes for easy removal of the apparently localized tumour. But on histological examination, tumour cells will be found permeating the white matter beyond the zone of gliosis. Thus in these tumours the surgeon removes a very wide margin of healthy brain if he hopes to extirpate the tumour. Unfortunately many of these tumours are already at the time of operation too extensive to allow of this.
The surgeon sorely needs some ancillary aid which will inform him whether or not he has got well beyond the tumour. The use of such things as fluorescein would seem to be an important help, indeed any method of showing up tumour tissue would be an outstanding advance in the surgery of gliomata.
The cerebral astrocytomata should at present be regarded as being irremovable in most patients. Operation is often necessary to relieve symptoms of raised intracranial pressure, and this incident having been successfully passed, surgery probably has little more to offer. The oligodendroglioma in some cases can only be dealt with on similar lines, but there is no doubt that when a tumour seems to the surgeon to be localized, he should endeavour to extirpate it. My experience with the cerebral ependvmomas has been small, and-in snite of Scherer's statements-the results disappointing. Nevertheless extirpation should be the method of choice until we know more about them. Before leaving the surgical aspects of gliomata, I would like to raise the question of non-dominant hemispherectomy for a tumour such as an oligodendroglioma or perhaps an astrocytoma which by such a radical procedure might be completely and permanently removed. I was much impressed by the recent report by Bell and Karnosh of such a case of astrocytoma, the patient being alive and well ten years afterwards. It would appear that the consequent disability is not so severe as might be expected. I think the possibilities of such operations should be explored, at any rate tentatively, and would be justified in view of the present position of the treatment of gliomata.
Finally a word must be said about radiotherapy for gliomata. An increasing number of such tumours are being treated in this way, and, in truth, we have nothing else to offer after the surgeon has performed some palliative operation. It is difficult to obtain a parallel series of cases with and without radiation, for no two cases are alike, and the similarity or otherwise of the tumours cannot be determined until a post mortem has been made. The comparison cannot be made as with, say, a series of cases of pituitary adenoma. But we have all seen individual patients in whom, judging by clinical methods, there is no shadow of doubt that radiation has caused retrogression of the tumour to a greater or less degree. And this holds good for each of the common types of glioma. Yet the hope of ultimate cure is negligible. This is a problem to be solved by the radiotherapists, and [ cannot help feeling that eventually the treatment of extensive malignant growths in general will lie in this direction, or with some similar physical method as yet undiscovered, or else along a biological approach. In the meantime it appears that radiotherapy leaves much to be desired. With the advent of high voltage apparatus, radionecrosis has become a recognized danger. There is also the possibility that at the borderline of maximum tolerance of the brain tissue, certain changes around a glioma described clearly by Carmichael and which may be a defence mechanism against invasion, may be endangered. Some of the unpredictable and surprisingly long survivals after partial removal of gliomas may be due not to radiation entirely, but to natural defences. If the brain has a natural defence against certain gliomata, it should never be damaged by irradiation. This is a problem to be studied along with that of the optimum time-dose factor for the gliomata.
Dr. Gerald Parsons-Smith: In a series of 150 verified cases of cerebral tumour I found that the electroencephalogram had some diagnostic value in cases of cerebral glioma.
The E.E.G. should show a focal abnormality in the affected hemisphere in the great majority of supratentorial gliomata even before the patient develops abnormal physical signs. Although such a unilateral focus was found in 88-5% of astrocytomata and 8700 of the malignant gliomata, the position of the maximum electrical abnormality was found to coincide with the actual site of the glioma in only 74% in each group. The E.E.G. should not be employed to demarcate the anatomical limits of a glioma, as this can usually be done more accurately by the various radiological methods, but rather it should be used to illustrate the extent and the degree of the abnormal brain tissue around a tumour, and also the direction of the tumour spread. It was a comparatively easy matter to distinguish the infiltrating lesions from such conditions as cerebral abscess and subdural hematoma, but the E.E.G. appearances produced by the various gliomata were not specific and it was not possible to differentiate between them. After operation and deep X-ray therapy the earliest evidence of recurrence of a glioma could be found in the E.E.G. which also reflected the slightest change in cerebral metabolism produced by the progress of a tumour in the posterior fossa.
Mr. G. Angiography was performed in 31 of the glioblastomata and in 27 of these a typical tumour pattern was seen. In only 4 was there no pattern. In general the massive vascular marking with numerous abnormal vessels gave the diagnosis, and in many cases we were thus able to avoid craniotomy.
A diffuse blush in the arterial phase sometimes led to difficulty but we have learnt that the blush of a meningioma usually occurs in the phlebograms. Secondary tumours, of which there were 10 in the same period, can mimic the typical appearance of a glioblastoma and in 3 of them there was a diffuse blush in the phlebograms which suggested meningioma. 22 angiograms were done in the 37 astrocytomata and all but 2 showed no tumour pattern at all. However, there was obvious distortion of one or more of the main cerebral vessels. In the two with the tumour pattern the diagnosis of astrocytoma was made on the sections although macroscopically we thought the tumours to be glioblastomata.
I think this apparent anomaly could be explained by dedifferentiation in these tumours. The numbers of the remaining gliomata are too small for useful analysis. We have also found the electroencephalogram of great value in localising the side of the tumour for subsequent arteriography. In our experience chronic subdural haematoma and cerebral abscess can nearly always be diagnosed by the electroencephalogram.
In view of the great shortage of hospital beds major operation on the gliomata are, therefore, avoided as far as possible.
After clinical examination an electroencephalogram is done to find on which side the tumour is situated if this is not already known.
If a percutaneous angiogram is equivocal as it is with mid-line tumours and some of the astrocytomata, ventriculography or encephalography is done.
The number of ventriculograms has fallen by nearly one-third.
